Bio
Manages the investment for Beringea’s ProVen Health VCT. Prior to joining Beringea, was an Associate Director of Healthcare Investment at Noble since May 2007 and Fund Manager of the Bloomsbury Bioseed Fund since November 2000. Before his role at Noble, was Associate Director, Worldwide Business Development, for SmithKline Beecham and was instrumental in the assessment and the negotiation of several major in-license deals and acquisitions. Also worked at the American consulting firm, ZS Associates, specialising on sales and marketing issues within the pharmaceutical industry. In addition, has been involved in the startup of a strategic consulting company specialising in R&D and marketing strategy for the biotech and healthcare industry, Double Helix Development. Doctor in Veterinary Medicine, a trained Veterinary Pathologist, specialising in Nasal Toxicology at the Chemical Industry Institute of Toxicology (CIIT) in North Carolina, and hold an MBA from INSEAD (Fontainebleau).
Career
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Beringea LtdEmail: [email protected] |
||
|
|
Bloomsbury Bioseed Fund LtdPublicly funded seed investor in science research coming out of certain UK universitiesEmail: [email protected] |